HOXB13 and breast carcinoma: In breast cancer, HOXB13 was found to be overexpressed in hormone-refractory tumors compared to hormone-responsive tumors, further suggesting that HOXB13 might be a useful prognostic marker for hormone-refractory breast cancers [26].